Pacira Biosciences Inc
SWB:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
SWB:82P
|
US |
|
Anheuser-Busch Inbev SA
MIL:1ABI
|
BE |
|
Lundin Mining Corp
TSX:LUN
|
CA |
|
F
|
Freeport-McMoRan Inc
DUS:FPMB
|
US |
|
G
|
Geron Corp
SWB:GON
|
US |
|
Schibsted ASA
OSE:SCHB
|
NO |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 25.36 EUR with a low forecast of 20.01 EUR and a high forecast of 34.38 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
25.36
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 25.36 EUR with a low forecast of 20.01 EUR and a high forecast of 34.38 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
110%
The compound annual growth rate for Operating Income over the next 3 years is 110%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
224%
The compound annual growth rate for Net Income over the next 3 years is 224%.
